ZUCLOPENTHIXOL ACETATE vs STANDARD DRUG CARE: Clinical response: no clinically significant response in mental state
ZUCLOPENTHIXOL ACETATE showed no clear difference in mental state: 1. No important improvement compared with STANDARD DRUG CARE (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
ZUCLOPENTHIXOL ACETATE vs STANDARD DRUG CARE Mental state: 1. No important improvement · patients with acute schizophrenia and similar serious mental illnesses ZUCLOPENTHIXOL ACETATE showed no clear difference in mental state: 1. No important improvement compared with STANDARD DRUG CARE (low certainty). Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses (2012) · Cochrane Headline outcomes only | RR 0.86 [0.39, 1.86] | 2 studies · 188 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses 2012 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.